Welcome to our dedicated page for UBS ETRACS Alerian MLP Index ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.
UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.
For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Marvell Technology, Inc., maturing on or about January 11, 2027. These unsecured debt obligations can pay periodic contingent coupons, but only when the stock closes at or above a preset coupon barrier on the relevant observation date.
The notes are subject to automatic call on monthly observation dates if the stock closes at or above its initial level, in which case holders receive the principal plus any due coupon and no further payments. If the notes are not called and the stock on the final valuation date is at or above a downside threshold, principal is repaid; if it is below that threshold, repayment is reduced in line with the stock’s decline and losses can reach 100% of the investment.
The minimum investment is 100 notes at $10 per note, and the estimated initial value is expected to be between $9.45 and $9.70 per note. All payments depend on the creditworthiness of UBS AG, and the notes will not be listed on any securities exchange.
UBS AG is offering $100,000 of Trigger Autocallable Contingent Yield Notes linked to Moderna, Inc. common stock, maturing January 11, 2027. These unsecured debt securities pay a contingent coupon only when Moderna’s closing share price on a monthly observation date is at or above a coupon barrier. The notes can be automatically called after two months if the share price is at or above the initial level, returning principal plus any due coupon, with no further payments.
If the notes are not called and Moderna’s final share price is at or above a downside threshold on the final valuation date, investors receive back the $10 principal per note, plus any final coupon if the barrier is met. If the final price is below the downside threshold, repayment is reduced in line with the stock’s decline, and investors can lose all of their investment. An example structure shows an 18.33% per annum contingent coupon and barriers set at 50% of the initial level. The minimum investment is 100 notes ($1,000), and the estimated initial value is $9.71 per $10 note. All payments depend on UBS’s credit.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Advanced Micro Devices, Inc., maturing on or about January 10, 2028. These unsecured debt notes pay a contingent coupon only if AMD’s closing share price on each observation date is at or above a preset coupon barrier; otherwise, no coupon is paid for that period.
The notes feature an automatic call: if AMD’s stock closes at or above the initial level on any observation date before maturity, investors receive the $10 principal per Note plus the contingent coupon for that period, and the notes terminate. If the notes are not called and AMD’s final share price is at or above a downside threshold, investors receive back the $10 principal per Note, potentially with a final coupon.
If the notes are not called and AMD’s final share price is below the downside threshold, repayment is reduced in line with AMD’s decline, and investors can lose some or all of their investment. All payments depend on UBS’s credit. The estimated initial value is expected to be between $9.49 and $9.74 per $10 Note.
UBS AG is offering $100,000 of Trigger Autocallable Contingent Yield Notes linked to the common stock of Freeport-McMoRan Inc., maturing on January 11, 2027. These unsecured debt notes pay a contingent coupon only when the stock closes at or above a preset coupon barrier on the relevant observation date; otherwise no coupon is paid for that period. The notes can be called early if the stock closes at or above the initial level on any observation date before the final valuation date, in which case investors receive principal plus any due coupon and no further payments. If the notes are not called and the stock finishes at or above a downside threshold at maturity, investors receive their principal back, but if it finishes below that threshold they incur a loss matching the stock’s decline and could lose their entire investment. The minimum investment is 100 notes at $10 each, and the estimated initial value is $9.76 per $10 note, with all payments subject to UBS’s creditworthiness.
UBS AG is offering $355,000 of Trigger Autocallable Contingent Yield Notes linked to Oracle Corporation common stock, maturing on January 10, 2028. These unsecured notes pay a high contingent coupon of 17.54% per annum (about $0.4385 per $10 note per period) only if Oracle’s share price on an observation date is at or above a coupon barrier set at $60.00, which is 60.00% of the initial level. The notes are automatically called, returning principal plus the coupon, if Oracle closes at or above the initial level on any observation date before maturity.
If not called, and Oracle’s final share price is at or above the downside threshold of $60.00, investors receive back their $10 principal per note plus any final coupon. If the final price is below the downside threshold, repayment is reduced dollar‑for‑dollar with Oracle’s decline using the formula $10 × (1 + underlying return), and investors can lose their entire investment. The notes are subject to UBS credit risk, are not FDIC insured, are expected to price at $10 with an estimated initial value of $9.80, and will not be listed on any exchange.
UBS AG is offering trigger autocallable contingent yield notes linked to the common stock of Moderna, Inc., with a trade date of January 7, 2026 and maturity on or about January 11, 2027. These unsecured debt notes pay a contingent coupon only if Moderna’s closing share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period.
The notes are automatically called early if, on any monthly observation date after two months, Moderna’s share price is at or above its initial level, in which case investors receive principal plus any due contingent coupon and no further payments. If the notes are not called and Moderna’s final level on the January 7, 2027 valuation date is at or above a downside threshold, investors receive their principal back; if it is below that threshold, repayment is reduced in line with the share price decline and can fall to zero.
The notes are issued in $10 denominations with a minimum investment of 100 notes, are not bank deposits, are not FDIC insured, and all payments depend on the creditworthiness of UBS. The estimated initial value per note is expected to be between $9.41 and $9.66, reflecting UBS’s internal pricing models.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Lam Research Corporation, maturing on January 10, 2028. These unsecured debt notes can pay contingent coupons on scheduled dates, but only if Lam Research’s share price on the relevant observation date is at or above a preset coupon barrier; otherwise, no coupon is paid.
The notes may be automatically called early if the share price on any observation date before maturity is at or above the initial level, in which case investors receive principal plus any due coupon and the product terminates. If not called, and the final share price on the valuation date is at or above a downside threshold, principal is repaid; if it is below that threshold, repayment is reduced in line with the share’s decline and investors can lose all of their investment. The minimum investment is $1,000, and the estimated initial value is $9.77 per $10 note, with all payments subject to UBS’s credit risk.
UBS AG is offering preliminary terms for Trigger Autocallable Contingent Yield Notes linked to the common stock of Freeport-McMoRan Inc., maturing on or about January 11, 2027. These unsecured debt notes pay a contingent coupon only if the stock closes at or above a coupon barrier on each observation date; otherwise no coupon is paid.
The notes are automatically called if the stock closes at or above the initial level on any observation date before the final valuation date, returning principal plus the applicable coupon and ending the investment early. If not called, investors receive full principal at maturity only if the final stock level is at or above a downside threshold. Below that threshold, repayment is reduced in line with the stock’s decline, and investors can lose their entire investment.
The minimum investment is 100 notes at $10 each. The estimated initial value per note on the trade date is expected to range between $9.46 and $9.71, based on UBS internal models. All payments depend on the creditworthiness of UBS, and the notes are not bank deposits or FDIC insured and will not be listed on an exchange.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Oracle Corporation, maturing on or about January 10, 2028. These unsecured debt securities pay a contingent coupon only if Oracle’s share price on an observation date is at or above a preset coupon barrier; otherwise no coupon is paid for that period. The Notes are automatically called before maturity if Oracle’s share price on any observation date (other than the final one) is at or above the initial level, in which case investors receive principal plus the applicable contingent coupon and no further payments.
If the Notes are not called and Oracle’s final share price on the final valuation date is at or above the downside threshold, investors receive their full principal back at maturity (plus any final contingent coupon if the barrier is met). If the final price is below the downside threshold, repayment is reduced in line with Oracle’s negative return, and investors can lose some or all of their principal. The minimum investment is 100 Notes at $10 per Note, and the estimated initial value per $10 Note is expected to be between $9.44 and $9.69. All payments depend on the creditworthiness of UBS, and the Notes will not be listed on any exchange.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Lam Research Corporation, maturing around January 10, 2028. These are unsecured, unsubordinated debt obligations of UBS with payments dependent on Lam Research’s share performance and UBS’s credit.
Holders receive a contingent coupon on each observation date only if the Lam Research share price is at or above a preset coupon barrier; otherwise no coupon is paid for that period. The notes are automatically called early if the share price on any observation date before maturity is at or above the initial level, in which case investors receive principal plus the applicable coupon and the product terminates.
If the notes are not called and the final share price is at or above a downside threshold, UBS repays principal at maturity; if it is below that threshold, repayment is reduced in line with the stock’s decline and can fall to zero. The denomination is $10 per note with a minimum of 100 notes, and the estimated initial value is expected to range from $9.47 to $9.72 per $10 note. The notes will not be listed on any exchange.